329-14870-22850
1 vaccination
4 coded responses
6 check-ins
4 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 61-65
- ZIP prefix
- 853 / AZ
- Registered
- 2021-03-30
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-29
Dose 1 — Moderna
-
2021-03-30
Registered in v-safe
-
2021-03-30
Survey response — days 1–6 daily, dose 1MedDRA: Hypoaesthesia, Neuralgia — Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Neuralgia - extreme nerve pain and numbnessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-31
-
2021-04-01
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Swelling · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-06-28
Survey response — 3 months, dose 1MedDRA: Anxiety, Depression, Multiple sclerosis, Pre-existing disease, Respiratory disorder — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Still having breathing problems. Dx depression/anxiety. MS symptoms exacerbatedMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-28
Report sent to call center — 3 months, dose 1Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-07-02
-
2021-09-29
Survey response — 6 months, dose 1MedDRA: Depression, Fatigue, Muscular weakness, Neuropathy peripheral, Office visit — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: Neuropathy, muscle weakness, fatigue, depression · Healthcare visit (other): Appointment in person with neurologist and PCPMedDRA releases: 2024-11 · check-in free text available
-
2021-09-29
Report sent to call center — 6 months, dose 1Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-10-01
-
2022-03-31
Survey response — 12 months, dose 1MedDRA: Brain fog, Fatigue, Lymphadenopathy, Multiple sclerosis, Muscular weakness, Pre-existing disease — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Swelling and enlarged lymph nodes in rt arm - 1st sign with Covid-19 and recurred with booster - not improving. Multiple sclerosis symptoms relapsing - brain fog, fatigue and muscle weakness since booster. Neurologist confirmed.MedDRA releases: 2024-11 · check-in free text available
-
2022-03-31
Report sent to call center — 12 months, dose 1Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-04-05
Call successfulDoes not wish to fill out VAERS report
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-29 | Moderna |
Call center
3 call center cases
3 successful
Free text
Release 6 — days 1–6 daily, dose 1
Systemic reaction (other): Neuralgia - extreme nerve pain and numbness
Release 9 — 3 months, dose 1
Symptoms: Still having breathing problems. Dx depression/anxiety. MS symptoms exacerbated
Release 9 — 6 months, dose 1
Symptoms: Neuropathy, muscle weakness, fatigue, depression
Healthcare visit (other): Appointment in person with neurologist and PCP
Release 11 — 12 months, dose 1
Symptoms: Swelling and enlarged lymph nodes in rt arm - 1st sign with Covid-19 and recurred with booster - not improving. Multiple sclerosis symptoms relapsing - brain fog, fatigue and muscle weakness since booster. Neurologist confirmed.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Anxiety | ✓ | ✓ | ✓ |
| SD | Brain fog | · | · | ✓ |
| SD | Depression | ✓ | ✓ | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Lymphadenopathy | · | · | ✓ |
| SD | Multiple sclerosis | ✓ | ✓ | ✓ |
| SD | Muscular weakness | · | · | ✓ |
| SD | Neuropathy peripheral | · | · | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SD | Respiratory disorder | ✓ | ✓ | ✓ |
| SRO | Hypoaesthesia | ✓ | ✓ | ✓ |
| SRO | Neuralgia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release